Astellas Pharma Inc (ALPMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALPMY | ONC | UTHR | ||
| Company | Astellas Pharma Inc | Beone Medicines Ltd | United Therapeutic | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 13.1400 | 320.84 | 491.00 | ||
| High | 13.6900 | 322.55 | 496.73 | ||
| Low | 13.0000 | 318.09 | 488.75 | ||
| Latest | 13.0800 | 319.06 | 493.99 | ||
| Change | -0.1270 | -1.78 | +5.48 | ||
| % Change | -0.96% | -0.55% | +1.12% | ||
| Volume | 288,600 | 179,600 | 638,800 | ||
| 20-Day Average Volume | 108,815 | 285,220 | 422,945 | ||
| Previous Close | 13.2070 | 320.84 | 488.51 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 12.6707 | 338.60 | 480.50 | ||
| 20-Day Raw Stochastic | 61.64% | 11.92% | 92.47% | ||
| 20-Day Relative Strength | 68.48 | 44.82 | 65.07 | ||
| Weighted Alpha | +40.21 | +65.15 | +40.66 | ||
| Today's Opinion | 100% Buy | 48% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 48% Buy | 100% Buy | ||
| Last Month's Opinion | 88% Buy | 88% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.55% since 12/05/25 | -1.19% since 12/05/25 | +0.96% since 12/05/25 | ||
| Low | 12.7800 on 12/08/25 | 315.50 on 12/10/25 | 474.59 on 12/08/25 | ||
| High | 13.6900 on 12/12/25 | 331.83 on 12/08/25 | 496.73 on 12/12/25 | ||
| 1-Month | |||||
| %Chg | +9.09% since 11/12/25 | -15.47% since 11/12/25 | +7.03% since 11/12/25 | ||
| Low | 11.9601 on 11/13/25 | 310.11 on 12/05/25 | 456.00 on 11/13/25 | ||
| High | 13.6900 on 12/12/25 | 385.22 on 11/17/25 | 496.73 on 12/12/25 | ||
| 3-Month | |||||
| %Chg | +14.24% since 09/12/25 | -1.63% since 09/12/25 | +21.97% since 09/12/25 | ||
| Low | 10.0300 on 10/14/25 | 306.00 on 10/23/25 | 396.12 on 09/15/25 | ||
| High | 13.6900 on 12/12/25 | 385.22 on 11/17/25 | 496.73 on 12/12/25 | ||
| 6-Month | |||||
| %Chg | +33.61% since 06/12/25 | +15.38% since 06/12/25 | +72.64% since 06/12/25 | ||
| Low | 9.1100 on 06/23/25 | 239.25 on 07/02/25 | 272.12 on 07/31/25 | ||
| High | 13.6900 on 12/12/25 | 385.22 on 11/17/25 | 496.73 on 12/12/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 23,900,180 | 38,031,412 | 21,033,772 | ||
| Shares Outstanding, K | 1,809,660 | 118,537 | 43,057 | ||
| Annual Sales | 12,621,330,000 | 3,810,240,000 | 2,877,400,000 | ||
| Annual Net Income | 334,930,000 | -644,790,000 | 1,195,100,000 | ||
| Last Quarter Sales | 3,555,940,000 | 1,412,280,000 | 799,500,000 | ||
| Last Quarter Net Income | 537,220,000 | 124,840,000 | 338,700,000 | ||
| 60-Month Beta | 0.19 | 0.45 | 0.86 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.30 on 10/30/25 | 1.09 on 11/06/25 | 7.16 on 10/29/25 | ||
| Latest Earnings Date | 02/03/26 | 02/26/26 | 02/25/26 | ||
| Most Recent Dividend | 0.170 on 09/26/25 | N/A | N/A | ||
| Next Ex-Dividends Date | 09/26/25 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 10.42 | 187.60 | 18.37 | ||